Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
9/20/2023
Chinese Drugmakers Hit a Fundraising and Licensing Slump in August (Ph...
9/19/2023
Novartis, BeiGene Agree to Terminate Deal for Cancer Drug Candidate
9/18/2023
GenScript Expands Range of Reagent Services, Adding Circular RNA and L...
9/17/2023
In China's Changing Economy, MNCs Must Rethink the Mantra of Going Big...
9/15/2023
U.S. and Other Foreign Venture Firms Pull Back From China's Biotech Se...
9/15/2023
Cure Genetics, Frametact to Develop Brain Disease Gene Therapies in $6...
9/14/2023
China to Manage Monkeypox as Category B Infectious Disease as Covid-19
9/14/2023
U.S.-China Track II Dialogue on Healthcare - July 2023 Consensus
9/13/2023
Are China's Healthcare and Biopharma Sectors Really Open for Investmen...
9/13/2023
AriBio, Shanghai Pharma to Commercialize Oral Alzheimer's Drug AR1001
9/13/2023
Clover Biopharma Launches Quadrivalent Influenza Vaccine in Mainland C...
9/13/2023
NHSA Issues the Notice on Further Advancing the Intelligent Review and...
9/8/2023
Recent Official and Executive Moves
9/7/2023
MSD Plans to Boost New Product Launch and Pharma R&D in China
9/6/2023
NMPA Solicits Comments on the Guidelines for the Inspection of Third-P...
9/1/2023
NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...
9/1/2023
Recent Executive Moves
8/31/2023
IQVIA: Chinese Retail Pharmacy Sales up 8.9% in MAT Q2/2023
8/31/2023
NMPA and Chinese Customs Announce Addition of Taizhou as a Drug Import...
8/31/2023
NHSA to Cancel Hospital Payment Rights for Drug and Consumable Procure...
8/31/2023
MC2 Thera and Huadong Pharma Enter LIcense Deal for Plague Psoriasis D...
8/31/2023
Recent Official and Executive Moves
8/30/2023
Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
8/29/2023
NMPA Announces OTC Switch of Paracetamol Orally Dispersion Tablet
8/29/2023
Former Star Official of China's Healthcare Reform and VBP Architect ...
8/29/2023
Mounjaro's China Approval Imminent as Domestic Competitors Enter Clini...
8/28/2023
Regulation of Drug and Medical Device Advertising in China: An Industr...
8/28/2023
Verastem Oncology Enters Partnerships with GenFleet Therapeutics to Ad...
8/25/2023
Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
8/25/2023
IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
Page:
19
/
333
Total number of articles:
9987
:
[First]
[<<]
[17]
[18]
[19]
[20]
[21]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit